BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12480866)

  • 1. Robust evidence is needed in treating acne.
    Garner S; Eady A; Avery T
    BMJ; 2002 Dec; 325(7377):1422. PubMed ID: 12480866
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibiotic resistance in acne: is it time to look beyond antibiotics and Propionobacterium acnes?
    Sardana K; Garg VK
    Int J Dermatol; 2014 Jul; 53(7):917-9. PubMed ID: 24738843
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibiotics in acne: time for a rethink.
    Simpson N
    Br J Dermatol; 2001 Feb; 144(2):225-7. PubMed ID: 11251550
    [No Abstract]   [Full Text] [Related]  

  • 4. Current management of acne.
    O'Loughlin S
    Ir Med J; 1997; 90(3):92-3. PubMed ID: 9183086
    [No Abstract]   [Full Text] [Related]  

  • 5. Bacteria and antimicrobial agents in the treatment of acne.
    Parry EJ; Griffiths CE
    Int J Dermatol; 1996 Apr; 35(4):249-51. PubMed ID: 8786181
    [No Abstract]   [Full Text] [Related]  

  • 6. Acne and Propionibacterium acnes.
    Bojar RA; Holland KT
    Clin Dermatol; 2004; 22(5):375-9. PubMed ID: 15556721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility of Propionibacterium acnes isolates from acne patients in Colombia.
    Mendoza N; Hernandez PO; Tyring SK; Haitz KA; Motta A
    Int J Dermatol; 2013 Jun; 52(6):688-92. PubMed ID: 23451873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bacterial resistance during anti-acne antibiotic therapy. How to limit the risk].
    Piérard GE; Arrese JE; Claessens N; Greimers R; Piérard-Franchimont C; Naeyaert JM
    Rev Med Liege; 1999 Feb; 54(2):100-4. PubMed ID: 10221062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propionibacterium acnes is a causative agent in periprosthetic infections - important implications for the treatment of acne vulgaris.
    Otto-Lambertz C; Jung N; Sunderkötter C
    J Dtsch Dermatol Ges; 2019 Apr; 17(4):454-455. PubMed ID: 30873723
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: a status report.
    Leyden JJ; Del Rosso JQ; Webster GF
    Dermatol Clin; 2009 Jan; 27(1):1-15. PubMed ID: 18984363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propionibacterium: resistance of acne to antibiotics.
    Oakley A; Rademaker M; Duffill M; Leng R; Shewan J
    N Z Med J; 1995 Feb; 108(993):43-4. PubMed ID: 7891939
    [No Abstract]   [Full Text] [Related]  

  • 12. Sensitivity of Propionibacterium acnes isolated from acne patients: comparative study of antimicrobial agents.
    Nishijima S; Kurokawa I; Kawabata S
    J Int Med Res; 1996; 24(6):473-7. PubMed ID: 8959531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility of Propionibacterium acnes isolated from acne vulgaris.
    Kurokawa I; Nishijima S; Kawabata S
    Eur J Dermatol; 1999; 9(1):25-8. PubMed ID: 9920982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonality and anatomic distribution on the skin of antibiotic resistant and sensitive Propionibacterium acnes.
    Lomholt HB; Kilian M
    Acta Derm Venereol; 2014 Sep; 94(5):534-8. PubMed ID: 24577497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
    Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB
    J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Apropos of recommendations concerning oral treatment of acne. An interview with the president S. Belaich. Interview by Hélne Allouch].
    Belaich S
    Presse Med; 1999 Nov; 28(37):2046-7. PubMed ID: 10605477
    [No Abstract]   [Full Text] [Related]  

  • 17. [Oral treatment of acne. Agence Française de Securité Sanitaire des Produits de Santé].
    Presse Med; 1999 Nov; 28(37):2044-5. PubMed ID: 10605476
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibiotic resistance of microbial strains isolated from Korean acne patients.
    Moon SH; Roh HS; Kim YH; Kim JE; Ko JY; Ro YS
    J Dermatol; 2012 Oct; 39(10):833-7. PubMed ID: 22779738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is antibiotic resistance in cutaneous propionibacteria clinically relevant? : implications of resistance for acne patients and prescribers.
    Eady AE; Cove JH; Layton AM
    Am J Clin Dermatol; 2003; 4(12):813-31. PubMed ID: 14640775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of mild to moderate acne].
    Chivot M
    Ann Dermatol Venereol; 2003 Jan; 130(1 Pt 2):132-5. PubMed ID: 12605143
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.